Literature DB >> 11007598

Description and validation of a novel liquid metal-free device for venous congestion plethysmography.

F Christ1, A Bauer, D Brügger, M Niklas, I B Gartside, J Gamble.   

Abstract

We present a newly developed electromechanical sensor with automated calibration for strain-gauge plethysmography (filtrass) and compare it to a conventional mercury-in-Silastic strain-gauge plethysmograph (MSG). Fluid filtration capacity (K(f)) and isovolumetric venous pressure (Piv) of the limb were assessed noninvasively with both devices in 29 healthy volunteers. We found significantly higher K(f) and Piv values with MSG [4.6 +/- 2.0 x 10(-3) ml. min(-1). mmHg(-1). 100 ml tissue(-1) (K(f) units; K(f)U) and 21.2 +/- 8.1 mmHg for Pvi], than with filtrass, giving values of 3.1 +/- 0.8 K(f)U and 15.1 +/- 7.1 mmHg. Because K(f) and Piv are profoundly influenced by the calibration, we investigated the quality of the calibration signal and its impact on the obtained values. We could show that the reproducibility of repeated calibrations was higher with filtrass (58% lower mean +/- SD). The data were grouped according to the quality of calibration, and we found no significant difference in K(f) and Piv between filtrass (3.0 +/- 0.7 K(f)U and 15.9 +/- 6.9 mmHg, respectively) and MSG with good calibration signal (3.3 +/- 0. 8 K(f)U and 18.6 +/- 7.1 mmHg, respectively; no significant difference). However, we obtained significantly higher MSG values (5. 6 +/- 2.0 K(f)U and 23.1 +/- 8.4 mmHg, respectively; P < 0.001) in the group with a bad calibration signal. We suggest that the filtrass sensor, which performs an automatic, standardized calibration procedure and shows a linear signal response to stretch, gives highly reproducible and reliable results and thus is more suitable for routine application.

Entities:  

Mesh:

Year:  2000        PMID: 11007598     DOI: 10.1152/jappl.2000.89.4.1577

Source DB:  PubMed          Journal:  J Appl Physiol (1985)        ISSN: 0161-7567


  8 in total

Review 1.  Venous occlusion plethysmography in cardiovascular research: methodology and clinical applications.

Authors:  I B Wilkinson; D J Webb
Journal:  Br J Clin Pharmacol       Date:  2001-12       Impact factor: 4.335

2.  Influence of different cuff inflation protocols on capillary filtration capacity in human calves -- a congestion plethysmography study.

Authors:  A Bauer; D Bruegger; J Gamble; F Christ
Journal:  J Physiol       Date:  2002-09-15       Impact factor: 5.182

3.  Contactless monitoring of the blood-flow changes in upper limbs.

Authors:  Valeriy V Zaytsev; Serguei V Miridonov; Oleg V Mamontov; Alexei A Kamshilin
Journal:  Biomed Opt Express       Date:  2018-10-12       Impact factor: 3.732

Review 4.  Methods for the determination of skeletal muscle blood flow: development, strengths and limitations.

Authors:  Lasse Gliemann; Stefan P Mortensen; Ylva Hellsten
Journal:  Eur J Appl Physiol       Date:  2018-05-14       Impact factor: 3.078

5.  The insulin sensitiser pioglitazone does not influence skin microcirculatory function in patients with type 2 diabetes treated with insulin.

Authors:  J E Tooke; L M Elston; K M Gooding; C I Ball; D M Mawson; J Piper; R Sriraman; R Urquhart; A C Shore
Journal:  Diabetologia       Date:  2006-03-01       Impact factor: 10.122

Review 6.  [Microcirculatory monitoring of sepsis].

Authors:  A Bauer; D Bruegger; F Christ
Journal:  Anaesthesist       Date:  2005-12       Impact factor: 1.041

7.  Circulating adenosine increases during human experimental endotoxemia but blockade of its receptor does not influence the immune response and subsequent organ injury.

Authors:  Bart P Ramakers; Niels P Riksen; Petra van den Broek; Barbara Franke; Wilbert H M Peters; Johannes G van der Hoeven; Paul Smits; Peter Pickkers
Journal:  Crit Care       Date:  2011-01-06       Impact factor: 9.097

8.  Microvascular permeability during experimental human endotoxemia: an open intervention study.

Authors:  Lucas T G J van Eijk; Peter Pickkers; Paul Smits; Wim van den Broek; Martijn P W J M Bouw; Johannes G van der Hoeven
Journal:  Crit Care       Date:  2005-02-21       Impact factor: 9.097

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.